Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03447470 |
| Title | Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Redx Pharma Plc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Royal Marsden Hospital, Institute of Cancer Research | Sutton | Surrey | SM2 5PT | United Kingdom | Details | |
| Guys Hospital | London | SE1 9RT | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details | ||
| Sir Bobby Robson Cancer Trials Research Centre | Newcastle | NE77DN | United Kingdom | Details | ||
| Department of Oncology | Oxford | OX3 7LE | United Kingdom | Details |